Vascular brain burden is the greatest determinant of late-life cognition. People with stroke are at increased risk of cognitive decline and dementia, and yet are usually excluded from intervention studies. We need to target high-risk populations to reduce dementia risk and identify genetic and protein markers for post-stroke cognitive decline.
We need to understand why Indigenous Australians are less likely to receive evidence-based-cardiovascular (CV) care despite being at higher risk for heart attack and stroke. To motivate change, we also need to demonstrate the health and economic savings that could be achieved if evidence-based-CV care were better implemented in this community.